Literature DB >> 19632576

Circulating and intrapulmonary C-reactive protein: a predictor of bronchiolitis obliterans syndrome and pulmonary allograft outcome.

Robin Vos1, Bart M Vanaudenaerde, Stéphanie I De Vleeschauwer, Anna Willems-Widyastuti, Hans Scheers, Dirk E Van Raemdonck, Lieven J Dupont, Geert M Verleden.   

Abstract

BACKGROUND: Elevated C-reactive protein (CRP) levels have been associated with allograft failure and recipient death in renal and cardiac transplantation. Data in lung transplantation (LTx) are lacking. We hypothesized that baseline plasma or bronchoalveolar lavage (BAL) CRP might be prognostic for the long-term outcome after LTx.
METHODS: This retrospective cohort study included 121 LTx recipients. Plasma CRP and BAL CRP, together with cell differentials, and interleukin-6 (IL-6) and IL-8 protein levels, were evaluated at 90 days after LTx and associated with bronchiolitis obliterans syndrome (BOS)-free and overall survival.
RESULTS: Plasma CRP, BAL CRP, and BAL neutrophilia, but not IL-6 or IL-8, were significantly increased in patients with BOS > or = 1 or not surviving at 3 years after LTx. In univariate analysis, plasma CRP > 5 mg/liter, elevated BAL CRP levels, and BAL neutrophilia > 15% were predictive for graft failure. In multivariate analysis, only BAL CRP was an independent predictor for graft failure (p = 0.004). A trend was seen for plasma CRP as a predictor (p = 0.077), but BAL neutrophilia was no longer an independent predictor.
CONCLUSIONS: Baseline CRP may be predictive for the long-term outcome after LTx. To confirm the present findings, prospective and longitudinal studies on a larger patient population are required.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19632576     DOI: 10.1016/j.healun.2009.05.011

Source DB:  PubMed          Journal:  J Heart Lung Transplant        ISSN: 1053-2498            Impact factor:   10.247


  5 in total

Review 1.  Bronchoalveolar lavage as a tool to predict, diagnose and understand bronchiolitis obliterans syndrome.

Authors:  V E Kennedy; J L Todd; S M Palmer
Journal:  Am J Transplant       Date:  2013-01-28       Impact factor: 8.086

Review 2.  Postinfectious Bronchiolitis Obliterans in Children: Diagnostic Workup and Therapeutic Options: A Workshop Report.

Authors:  Silvija-Pera Jerkic; Folke Brinkmann; Alistair Calder; Alicia Casey; Megan Dishop; Matthias Griese; Geoffrey Kurland; Mandy Niemitz; Sylvia Nyilas; Dirk Schramm; Ralf Schubert; Michael Tamm; Stefan Zielen; Martin Rosewich
Journal:  Can Respir J       Date:  2020-01-30       Impact factor: 2.409

Review 3.  Effector immune cells in chronic lung allograft dysfunction: A systematic review.

Authors:  Saskia Bos; Andrew J Filby; Robin Vos; Andrew J Fisher
Journal:  Immunology       Date:  2022-03-01       Impact factor: 7.215

4.  Multiplex protein profiling of bronchoalveolar lavage in idiopathic pulmonary fibrosis and hypersensitivity pneumonitis.

Authors:  Stijn Willems; Willems Stijn; Stijn E Verleden; Bart M Vanaudenaerde; Marijke Wynants; Wynants Marijke; Christophe Dooms; Dooms Christophe; Jonas Yserbyt; Yserbyt Jonas; Jana Somers; Somers Jana; Eric K Verbeken; Geert M Verleden; Wim A Wuyts
Journal:  Ann Thorac Med       Date:  2013-01       Impact factor: 2.219

5.  Significance of new lung infiltrates in outpatients after lung and heart-lung transplantation.

Authors:  V Díaz-Ravetllat; M Greer; A Haverich; G Warnecke; M Dierich; T Welte; J Gottlieb
Journal:  Transpl Infect Dis       Date:  2014-04-12       Impact factor: 2.228

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.